Alyeska Investment Group’s Trevi Therapeutics TRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.56M Buy
+650,000
New +$3.56M 0.01% 444
2020
Q1
Sell
-60,765
Closed -$228K 450
2019
Q4
$228K Buy
60,765
+230
+0.4% +$863 ﹤0.01% 348
2019
Q3
$272K Sell
60,535
-39,584
-40% -$178K ﹤0.01% 339
2019
Q2
$751K Buy
+100,119
New +$751K 0.01% 346